Skip to main content

Table 2 The relationship between patient demographics, pre- and post-operational characteristics and mortality in children who underwent surgical treatment of myelomeningocele

From: 2- to 20-year myelomeningocele follow-up outcomes from a referral center in Southern Iran: the Shiraz experience

MMC patients

GMFCS Level I and II (n = 54)

GMFCS Level III (n = 26)

GMFCS Level IV (n = 27)

GMFCS Level V (n = 18)

Total (%)

p value

Mean age at surgery, days (SD)

11.21 (7.326)

9.12 (7.384)

10.59 (6.326)

13.62 (20.425)

0.102a

Sex

     

0.045b

 Female

24

17

9

12

62 (50%)

 

 Male

30

9

18

6

63 (50%)

 

Dura closure

     

0.076b

 Autologous dura

26

17

13

13

69 (56%)

 

 Synthetic dura

28

9

14

4

55 (44%)

 

Readmission

     

0.064b

 No readmission

25

12

10

6

53 (42%)

 

 One time

18

12

9

6

45 (36%)

 

 Two times

8

1

3

4

16 (13%)

 

 Three times

3

0

0

1

4 (3%)

 

 Four or more times

0

0

5

1

6 (5%)

 

Urinary

     

0.008b

 Continent

19

4

6

0

29 (23%)

 

 Incontinent

35

22

21

18

96 (77%)

 

Bowel

     

0.029b

 Continent

20

6

8

1

35 (28%)

 

 Incontinent

34

19

20

17

90 (72%)

 

MMT grading

     

0.000d

 0

3

2

11

12

28 (23%)

 

 1

2

5

2

2

11 (9%)

 

 2

0

4

3

2

9 (7%)

 

 3

14

9

8

1

32 (26%)

 

 4

21

4

1

1

27 (22%)

 

 5

14

1

0

0

15 (10%)

 
  1. A bold p-value indicates that the variable is significantly associated with the outcome
  2. MMC myelomeningocele, SD standard deviation
  3. aStudent’s t-test,
  4. bFisher’s exact test